NCCN Guidelines for Patients® | Multiple Myeloma - page 33

33
NCCN Guidelines for Patients™: Multiple Myeloma
Version 1.2012
Par t 8
Par t 7
Par t 6
Par t 5
Par t 4
Par t 3
Par t 2
Par t 1
3.5 Tools
Am I considered a candidate for high-dose
chemotherapy and autologous stem cell transplant?
If two autologous transplants are considered, what is
the optimal timing? For example, should the second
one be planned in advance or deferred until a relapse?
Am I a candidate for an allogeneic stem cell transplant?
If so, how should my family members be tested to see if
their bone marrow matches mine?
Should the allogeneic transplant be the first transplant,
or should this transplant only be done if the cancer
worsens after a prior autologous transplant?
What are the risks of each of these strategies, both
short-term and long-term?
How long do each of these strategies control the
myeloma, and what are the chances of long-term
control or even cure?
If I can’t have a stem cell transplant, what are the
other options?
Questions about stem cell transplants to ask your doctor
1...,23,24,25,26,27,28,29,30,31,32 34,35,36,37,38,39,40,41,42,43,...84
Powered by FlippingBook